Jose-Tomás Navarro (Jose-Tomas Navarro, José-Tomas Navarro, José-Tomás Navarro)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Venues

Cancers

Clinical case reports

Histopathology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Huguet, Jose-Tomás Navarro, José Moltó, Josep-María Ribera, Gustavo Tapia
Diffuse Large B-Cell Lymphoma in the HIV Setting. Cancers 15 (12) (2023)
Maria Huguet, Jose-Tomás Navarro, José Moltó, Josep-María Ribera, Gustavo Tapia
Diffuse Large B-Cell Lymphoma in the HIV Setting. Cancers 15 (12) (2023)
Marta Canelo-Vilaseca, Gustavo Tapia, Elisa Orna, Marc Sorigué, Isabel Granada, Azahara Palomar-Muñoz, Ana Castillo, Javier Grau, Alba Mesa, Josep-María Ribera, Juan-Manuel Sancho, Jose-Tomás Navarro
HHV8 and EBV-negative primary effusion-based lymphoma: A case report of a new provisional entity and review of literature. Clinical case reports 11 (5) (2023)
Marta Canelo-Vilaseca, Gustavo Tapia, Elisa Orna, Marc Sorigué, Isabel Granada, Azahara Palomar-Muñoz, Ana Castillo, Javier Grau, Alba Mesa, Josep-María Ribera, Juan-Manuel Sancho, Jose-Tomás Navarro
HHV8 and EBV-negative primary effusion-based lymphoma: A case report of a new provisional entity and review of literature. Clinical case reports 11 (5) (2023)
Maria Joao Baptista, Gustavo Tapia, Ana-María Muñoz-Marmol, Josep Muncunill, Olga Garcia, Silvia Montoto, John G Gribben, Maria Calaminici, Antonio Martinez, Luis Veloza, Alejandra Martínez-Trillos, Teresa Aldamiz, Javier Menarguez, María-José Terol, Antonio Ferrandez, Miguel Alcoceba, Javier Briones, Eva González-Barca, Fina Climent, Ana Muntañola, José-María Moraleda, Mariano Provencio, Pau Abrisqueta, Eugenia Abella, Lluis Colomo, Carlos García-Ballesteros, Montserrat Garcia-Caro, Juan-Manuel Sancho, Josep-Maria Ribera, José-Luis Mate, Jose-Tomás Navarro
Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications. Histopathology 81 (6) (2022)
Miriam Verdu-Bou, Gustavo Tapia, Agueda Hernandez-Rodriguez, Jose-Tomás Navarro
Clinical and Therapeutic Implications of Epstein-Barr Virus in HIV-Related Lymphomas. Cancers 13 (21) (2021)
Fabian Frontzek, Annette M Staiger, Myroslav Zapukhlyak, Wendan Xu, Irina Bonzheim, Vanessa Borgmann, Philip Sander, Maria Joao Baptista, Jan-Niklas Heming, Philipp Berning, Ramona Wullenkord, Tabea Erdmann, Mathias Lutz, Pia Veratti, Sophia Ehrenfeld, Kirsty Wienand, Heike Horn, John R Goodlad, Matthew R Wilson, Ioannis Anagnostopoulos, Mario Lamping, Eva González-Barca, Fina Climent, Antonio Salar-Silvestre, Josep Castellví, Pau Abrisqueta, Javier Menarguez, Teresa Aldamiz, Julia Richter, Wolfram Klapper, Alexandar Tzankov, Stefan Dirnhofer, Andreas Rosenwald, José Luis Mate, Gustavo Tapia, Peter Lenz, Christoph Cornelius Miething, Wolfgang Hartmann, Björn Chapuy, Falko Fend, German Ott, Jose-Tomás Navarro, Michael Grau, Georg Lenz
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma. Nature communications 12 (1) (2021)
Jorge J Castillo, Thomas Guerrero-Garcia, Francesco Baldini, Emmanuelle Tchernonog, Guillaume Cartron, Slavisa Ninkovic, Kate Cwynarski, Daan Dierickx, Thomas Tousseyn, Frederick Lansigan, Yevgeny Linnik, Renzo Mogollon, Jose-Tomás Navarro, Adam J Olszewski, John L Reagan, Pasquale Fedele, Michael Gilbertson, George Grigoriadis, Michele Bibas
Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma. British journal of haematology 184 (4) (2018)

Jose-Tomás Navarro.css-eqlu8i{font-size:small;padding-left:4px;} (Jose-Tomas Navarro, José-Tomas Navarro, José-Tomás Navarro)

Publication Activity (10 Years)

Top Topics

Top Venues

Jose-Tomás Navarro (Jose-Tomas Navarro, José-Tomas Navarro, José-Tomás Navarro)